Showing results (101-110 of 126) with videos related to

Sort By:
Pageof 13
BMJ Open|December 10, 2015
Protocol of the adaptive study of IL-2 dose frequency on regulatory T cells in type 1 diabetes (DILfrequency): a mechanistic, non-randomised, repeat dose, open-label, response-adaptive studyLucy A Truman, Marcin L Pekalski, Paula Kareclas, et al.
Archives of Physical Medicine and Rehabilitation|November 6, 2021
Skilled Nursing and Inpatient Rehabilitation Facility Use by Medicare Fee-for-Service Beneficiaries Discharged Home After a Stroke: Findings From the COMPASS TrialJanet K Freburger, Amy M Pastva, Sylvia W Coleman, et al.
Clinical Pharmacology and Therapeutics|December 21, 2024
Investigational Use of Real-World Data as a Hybrid Control in Pancreatic Ductal Adenocarcinoma From the Randomized Phase Ib/II MORPHEUS TrialAndrew H Ko, Do-Youn Oh, Janet Lau, et al.
The British Journal of Dermatology|October 14, 2024
A personalized and systematically designed adherence intervention improves photoprotection in adults with xeroderma pigmentosum (XP): results of the XPAND randomized controlled trialJessica Walburn, Sam Norton, Robert Sarkany, et al.
Medical Care|February 2, 2023
Post-acute Ambulatory Care Service Use Among Patients Discharged Home After Stroke or TIA: The Cluster-randomized COMPASS StudyAnna M Kucharska-Newton, Jacquie R Halladay, Matthew A Psioda, et al.
Lancet (London, England)|September 13, 2011
Primary care referral to a commercial provider for weight loss treatment versus standard care: a randomised controlled trialSusan A Jebb, Amy L Ahern, Ashley D Olson, et al.
American Journal of Respiratory and Critical Care Medicine|September 23, 2020
Pharmacotherapy and Lung Function Decline in Patients with Chronic Obstructive Pulmonary Disease. A Systematic ReviewBartolome R Celli, Julie A Anderson, Nicholas J Cowans, et al.
Frontiers in Molecular Neuroscience|September 4, 2024
C286, an orally available retinoic acid receptor β agonist drug, regulates multiple pathways to achieve spinal cord injury repairMaria B Goncalves, Yue Wu, Earl Clarke, et al.
BMC Medicine|March 2, 2018
Adaptive designs in clinical trials: why use them, and how to run and report themPhilip Pallmann, Alun W Bedding, Babak Choodari-Oskooei, et al.
JCI Insight|October 5, 2018
The DILfrequency study is an adaptive trial to identify optimal IL-2 dosing in patients with type 1 diabetesEleonora Seelig, James Howlett, Linsey Porter, et al.
Pageof 13